Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 3
2006 3
2007 1
2008 3
2009 3
2010 3
2011 5
2012 3
2013 2
2014 1
2015 3
2016 6
2017 2
2018 1
2019 3
2020 5
2021 6
2022 11
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

62 results

Results by year

Filters applied: . Clear all
Page 1
Heterologous booster with a novel formulation containing glycosylated trimeric S protein is effective against Omicron.
Bottero D, Rudi E, Martin Aispuro P, Zurita E, Gaillard E, Gonzalez Lopez Ledesma MM, Malito J, Stuible M, Ambrosis N, Durocher Y, Gamarnik AV, Wigdorovitz A, Hozbor D. Bottero D, et al. Among authors: gamarnik av. Front Immunol. 2023 Nov 10;14:1271209. doi: 10.3389/fimmu.2023.1271209. eCollection 2023. Front Immunol. 2023. PMID: 38022542 Free PMC article.
Dengue virus NS5 degrades ERC1 during infection to antagonize NF-kB activation.
Gonzalez Lopez Ledesma MM, Costa Navarro G, Pallares HM, Paletta A, De Maio F, Iglesias NG, Gebhard L, Oviedo Rouco S, Ojeda DS, de Borba L, Giraldo M, Rajsbaum R, Ceballos A, Krogan NJ, Shah PS, Gamarnik AV. Gonzalez Lopez Ledesma MM, et al. Among authors: gamarnik av. Proc Natl Acad Sci U S A. 2023 Jun 6;120(23):e2220005120. doi: 10.1073/pnas.2220005120. Epub 2023 May 30. Proc Natl Acad Sci U S A. 2023. PMID: 37252973 Free PMC article.
Immunological study of COVID-19 vaccine candidate based on recombinant spike trimer protein from different SARS-CoV-2 variants of concern.
Rudi E, Martin Aispuro P, Zurita E, Gonzalez Lopez Ledesma MM, Bottero D, Malito J, Gabrielli M, Gaillard E, Stuible M, Durocher Y, Gamarnik AV, Wigdorovitz A, Hozbor D. Rudi E, et al. Among authors: gamarnik av. Front Immunol. 2022 Sep 29;13:1020159. doi: 10.3389/fimmu.2022.1020159. eCollection 2022. Front Immunol. 2022. PMID: 36248791 Free PMC article.
Humoral response and neutralising capacity at 6 months post-vaccination against COVID-19 among institutionalised older adults in Argentina.
Rodriguez PE, Silva AP, Miglietta EA, Rall P, Pascuale CA, Ballejo C, López Miranda L, Ríos AS, Ramis L, Marro J, Poncet V, Mazzitelli B, Salvatori M, Ceballos A, Gonzalez Lopez Ledesma MM, Ojeda DS, Aguirre MF, Miragaya Y, Gamarnik AV, Rossi AH; Laboratorio SeVa Group; PAMI Group. Rodriguez PE, et al. Among authors: gamarnik av. Front Immunol. 2022 Sep 26;13:992370. doi: 10.3389/fimmu.2022.992370. eCollection 2022. Front Immunol. 2022. PMID: 36225925 Free PMC article.
Immunogenicity and reactogenicity of heterologous immunization against SARS CoV-2 using Sputnik V, ChAdOx1-S, BBIBP-CorV, Ad5-nCoV, and mRNA-1273.
Pascuale CA, Varese A, Ojeda DS, Pasinovich ME, Lopez L, Rossi AH, Rodriguez PE, Miglietta EA; Laboratorio SeVa Group; Mazzitelli I, Di Diego Garcia F, Sanchez L, Rouco SO, Gonzalez Lopez Ledesma MM, Zurano JP, Mazzitelli B, Scruzzi G, Barbero P, Cardozo D, Gallego S, Borda M, Diaz M; Ministerio de Salud de la Provincia de Córdoba Group; UNC-Fac. Cs. Médicas-InViV Group; Ridao F, Rosales AB; Ministerio de Salud de la Provincia de La Rioja Group; Bhon J, Talia JM, Diangelo ME, Lacaze MA; Ministerio de Salud de la Provincia de San Luis Group; Aime B, Gutierrez SI, Ercole R, Toro R, Tau L, Delaplace L, Compagnucci MF; Universidad Nacional de La Plata Group; Sartori C, Desimone I, Echegoyen C, Velazquez P, Testa C; Ministerio de Salud de la Provincia de Buenos Aires Group; Hozbor D, Docena G, Laino CH, Kreplak N, Pifano M, Barbas G, Rearte A, Vizzotti C, Castelli JM, Geffner J, Gamarnik AV. Pascuale CA, et al. Among authors: gamarnik av. Cell Rep Med. 2022 Aug 16;3(8):100706. doi: 10.1016/j.xcrm.2022.100706. Epub 2022 Aug 3. Cell Rep Med. 2022. PMID: 35926505 Free PMC article.
Heterologous booster response after inactivated virus BBIBP-CorV vaccination in older people.
Rouco SO, Rodriguez PE, Miglietta EA, Rall P, Ledesma MMGL, Varese A, Pascuale CA, Ojeda DS, Mazzitelli B, Sanchez L, Ceballos A, Perez E, Geffner J, Miragaya Y, Rossi AH, Gamarnik AV. Rouco SO, et al. Among authors: gamarnik av. Lancet Infect Dis. 2022 Aug;22(8):1118-1119. doi: 10.1016/S1473-3099(22)00427-3. Epub 2022 Jun 28. Lancet Infect Dis. 2022. PMID: 35777383 Free PMC article. No abstract available.
Insights into the product release mechanism of dengue virus NS3 helicase.
Adler NS, Cababie LA, Sarto C, Cavasotto CN, Gebhard LG, Estrin DA, Gamarnik AV, Arrar M, Kaufman SB. Adler NS, et al. Among authors: gamarnik av. Nucleic Acids Res. 2022 Jul 8;50(12):6968-6979. doi: 10.1093/nar/gkac473. Nucleic Acids Res. 2022. PMID: 35736223 Free PMC article.
62 results